A1c

Why dialing back diabetes treatment is a good ideaA new study has unbelievable findings about treating Medicare patients with diabetes.
New diabetes drug set to rival TrulicityIf it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly’s dulaglutide (Trulicity).
Five Reasons to Become a Diabetes Educator
Five Reasons to Become a Diabetes EducatorWhy it's a good time to become more involved in diabetes education.